Rabies Vaccine, Lyophilized (Powder), 2.5 IU/dose

This tender is for the procurement of Rabies Vaccine, lyophilized (powder) form, with a dosage of 2.5 IU/dose. The procurement is conducted in accordance with Resolution of the Cabinet of Ministers of Ukraine No. 1178 dated October 12, 2022, and Resolution No. 822 dated September 14, 2020, concerning the formation and use of an electronic catalog. A key condition is that the offered product must not originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. The vaccine falls under CPV code 33650000-1 (General anti-infectives for systemic use, vaccines, antineoplastics and immunomodulators). The procuring entity is the Communal Enterprise "Gorokhivska Multipurpose Hospital of the Gorokhiv City Council". This procurement is critical for public health, ensuring the availability of a vital vaccine for post-exposure prophylaxis against rabies. The adherence to electronic catalog procedures and origin restrictions are standard practices in Ukrainian public procurement.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Vaccines. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 79,049.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.